iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Chesley Taft & Associates LLC

Chesley Taft & Associates LLC reduced its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 18.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,698 shares of the financial services provider’s stock after selling 5,860 shares during the quarter. Chesley Taft & Associates LLC owned 0.05% of iShares Biotechnology ETF worth $3,530,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in IBB. PVG Asset Management Corp purchased a new position in iShares Biotechnology ETF in the second quarter valued at about $415,000. Huntington National Bank raised its holdings in shares of iShares Biotechnology ETF by 17.9% during the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after buying an additional 160 shares during the period. National Bank of Canada FI boosted its holdings in iShares Biotechnology ETF by 5.9% in the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after acquiring an additional 229 shares during the period. First Financial Bank Trust Division acquired a new stake in iShares Biotechnology ETF in the third quarter valued at approximately $204,000. Finally, Thrive Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter valued at approximately $445,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $132.65 on Tuesday. The firm has a fifty day simple moving average of $136.32 and a 200-day simple moving average of $141.84. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.